Attorneys general from 15 states including Oregon, Illinois, New York and California jointly announced a $335 million settlement with opioid maker Mylan Inc.
The company, which is now part of Viatris, has manufactured generic fentanyl patches, oxycodone, hydrodocone and buprenorphine products since 2005, according to the Oregon Department of Justice.
“The attorneys general allege Mylan deceptively promoted its products as less prone to abuse despite knowing for years that many of its opioid products — particularly its fentanyl patches — were actually more vulnerable to abus...
Comments